Invention Grant
- Patent Title: 5-substituted isoindoline compounds
- Patent Title (中): 5-取代的异二氢吲哚化合物
-
Application No.: US14490554Application Date: 2014-09-18
-
Publication No.: US09447070B2Publication Date: 2016-09-20
- Inventor: George W. Muller , Roger Shen-Chu Chen , Alexander L. Ruchelman
- Applicant: CELGENE CORPORATION
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/454 ; C07D401/04 ; C07D405/14 ; C07D409/14 ; C07D413/14 ; A61K31/4545 ; A61K31/4709 ; A61K31/4725 ; A61K31/496 ; A61K31/501 ; A61K31/5377
Abstract:
This invention relates to 5-substituted isoindoline compounds, and pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.
Public/Granted literature
- US20150005303A1 5-SUBSTITUTED ISOINDOLINE COMPOUNDS Public/Granted day:2015-01-01
Information query
